Does Topiramate Interact with Alogliptin And Pioglitazone?
Topiramate and Alogliptin And Pioglitazone have a moderate drug interaction according to U.S. FDA drug labeling data. Decreases pioglitazone and active metabolite exposure. Monitor patients for adequate glycemic control when used concomitantly. The mechanism involves decreases pioglitazone exposure and active metabolites. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Topiramate Class
- Cytochrome P450 3A4 Inducers
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Topiramate and Alogliptin And Pioglitazone occurs because decreases pioglitazone exposure and active metabolites. Clinically, this means decreases pioglitazone and active metabolite exposure. monitor patients for adequate glycemic control when used concomitantly. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Topiramate and your doctor is considering prescribing Alogliptin And Pioglitazone (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider